https://www.selleckchem.com/pr....oducts/ci994-tacedin
6% versus 80.8%; p = 0.98). Freedom from all-cause death and from severe complication in the study period were also similar (all-cause death, 91.6% versus 88.7%, p = 0.70; severe complication, 89.7% versus 91.5%, p = 0.75). On multivariate analysis, sick sinus syndrome (hazard ratio (HR) 2.7, 95% confidence interval (CI) 1.1-6.4, p = 0.03), immunosuppressant use (HR 21 (95% CI 3.3-134), p less then 0.01), and high C-reactive protein (HR 1.5 (95% CI 1.2-1.9), p less then 0.01) were independent predictors of primary outcome. Co
Like
Comment
Share
